Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)
Approches Génétiques Intégrées et Nouvelles Thérapies pour les Maladies Rares (INTEGRARE)
France
1 November 2019 - 31 October 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) published between 1 November 2019 - 31 October 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Research collaboration: Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
2 | 0.95 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 2 | 0.95 |
Top articles by Altmetric score in current window
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies
Nature Medicine
2020-06-01
Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A
Science Translational Medicine
2019-11-27
1 November 2019 - 31 October 2020
International vs. domestic collaboration by Share
- 50.26% Domestic
- 49.74% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (5 total)
- Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE), France
- Domestic institution
Top 10 international collaborators by Share (3 total)
- Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE), France
- Foreign institution
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Participating institutions
Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.